Literature DB >> 15937691

Severe vascular disturbance in a case of familial brain calcinosis.

Judit Miklossy1, Ian R Mackenzie, Katerina Dorovini-Zis, Donald B Calne, Zbigniew K Wszolek, Andis Klegeris, Patrick L McGeer.   

Abstract

Here we present the first neuropathological study of a case of autosomal dominant brain calcinosis in a family followed through five generations. The 71-year-old female who came to autopsy had unusually severe and extensive bilateral brain calcifications. The process appeared to start with deposition of minute calcium-positive spheroids of less than 1 mum in diameter in capillaries that otherwise appeared normal. These could be observed extending to areas distant from the main pathology. In more advanced stages, larger spheroids completely covered some capillaries while sparing others. In heavily affected regions, ghost capillaries were observed where only calcium spheroids remained after endothelial cells and basement membranes had disappeared. Vessels of all sizes were affected, and large accretions were observed in the basal ganglia, thalamus and cerebellum. Combined scanning electron microscopy and X-ray spectrometry of these large deposits revealed a dominant presence of calcium and phosphorous, plus carbon and oxygen indicative of organic material, and small amounts of sodium, potassium, sulfur, and magnesium. Reactive astrocytes and reactive microglia accumulated around the calcified deposits, indicating a mild ongoing inflammatory process. The results suggest that severe vascular impairment and mild inflammation contribute to the slow but inexorable progression of hereditary brain calcinosis.

Entities:  

Mesh:

Year:  2005        PMID: 15937691     DOI: 10.1007/s00401-005-1007-7

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  32 in total

1.  Diagnostic Value of Brain Calcifications in Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia.

Authors:  T Konno; D F Broderick; N Mezaki; A Isami; D Kaneda; Y Tashiro; T Tokutake; B M Keegan; B K Woodruff; T Miura; H Nozaki; M Nishizawa; O Onodera; Z K Wszolek; T Ikeuchi
Journal:  AJNR Am J Neuroradiol       Date:  2016-09-15       Impact factor: 3.825

2.  Genetic screening and functional characterization of PDGFRB mutations associated with basal ganglia calcification of unknown etiology.

Authors:  Monica Sanchez-Contreras; Matthew C Baker; NiCole A Finch; Alexandra Nicholson; Aleksandra Wojtas; Zbigniew K Wszolek; Owen A Ross; Dennis W Dickson; Rosa Rademakers
Journal:  Hum Mutat       Date:  2014-06-03       Impact factor: 4.878

3.  New Data from Pdfgb ret/ret Mutant Mice Might Lead to a Paradoxical Association Between Brain Calcification, Pericytes Recruitment and BBB Integrity.

Authors:  Denis A P Moura; Roberta R Lemos; João R M Oliveira
Journal:  J Mol Neurosci       Date:  2017-11-02       Impact factor: 3.444

4.  Expression of osteogenic molecules in the caudate nucleus and gray matter and their potential relevance for Basal Ganglia calcification in hypoparathyroidism.

Authors:  Ravinder Goswami; Tabin Millo; Shruti Mishra; Madhuchhanda Das; Mansi Kapoor; Neeraj Tomar; Soma Saha; Tara Shankar Roy; Vishnubhatla Sreenivas
Journal:  J Clin Endocrinol Metab       Date:  2014-02-19       Impact factor: 5.958

5.  Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice.

Authors:  Annika Keller; Ana Westenberger; Maria J Sobrido; Maria García-Murias; Aloysius Domingo; Renee L Sears; Roberta R Lemos; Andres Ordoñez-Ugalde; Gael Nicolas; José E Gomes da Cunha; Elisabeth J Rushing; Michael Hugelshofer; Moritz C Wurnig; Andres Kaech; Regina Reimann; Katja Lohmann; Valerija Dobričić; Angel Carracedo; Igor Petrović; Janis M Miyasaki; Irina Abakumova; Maarja Andaloussi Mäe; Elisabeth Raschperger; Mayana Zatz; Katja Zschiedrich; Jörg Klepper; Elizabeth Spiteri; Jose M Prieto; Inmaculada Navas; Michael Preuss; Carmen Dering; Milena Janković; Martin Paucar; Per Svenningsson; Kioomars Saliminejad; Hamid R K Khorshid; Ivana Novaković; Adriano Aguzzi; Andreas Boss; Isabelle Le Ber; Gilles Defer; Didier Hannequin; Vladimir S Kostić; Dominique Campion; Daniel H Geschwind; Giovanni Coppola; Christer Betsholtz; Christine Klein; Joao R M Oliveira
Journal:  Nat Genet       Date:  2013-08-04       Impact factor: 38.330

6.  Interplay between primary familial brain calcification-associated SLC20A2 and XPR1 phosphate transporters requires inositol polyphosphates for control of cellular phosphate homeostasis.

Authors:  Uriel López-Sánchez; Sandrine Tury; Gaël Nicolas; Miranda S Wilson; Snejana Jurici; Xavier Ayrignac; Valérie Courgnaud; Adolfo Saiardi; Marc Sitbon; Jean-Luc Battini
Journal:  J Biol Chem       Date:  2020-05-11       Impact factor: 5.157

7.  PDGFRB mutants found in patients with familial infantile myofibromatosis or overgrowth syndrome are oncogenic and sensitive to imatinib.

Authors:  F A Arts; D Chand; C Pecquet; A I Velghe; S Constantinescu; B Hallberg; J-B Demoulin
Journal:  Oncogene       Date:  2015-10-12       Impact factor: 9.867

8.  SLC20A2 and THAP1 deletion in familial basal ganglia calcification with dystonia.

Authors:  Matt Baker; Audrey J Strongosky; Monica Y Sanchez-Contreras; Shan Yang; Will Ferguson; Donald B Calne; Susan Calne; A Jon Stoessl; Judith E Allanson; Daniel F Broderick; Michael L Hutton; Dennis W Dickson; Owen A Ross; Zbigniew K Wszolek; Rosa Rademakers
Journal:  Neurogenetics       Date:  2013-10-18       Impact factor: 2.660

9.  Familial idiopathic basal ganglia calcification: a challenging clinical-pathological correlation.

Authors:  Christian Wider; Dennis W Dickson; Katherine J Schweitzer; Daniel F Broderick; Zbigniew K Wszolek
Journal:  J Neurol       Date:  2009-03-01       Impact factor: 4.849

10.  Microstructure and mineral composition of dystrophic calcification associated with the idiopathic inflammatory myopathies.

Authors:  Naomi Eidelman; Alan Boyde; Andrew J Bushby; Peter G T Howell; Jirun Sun; Dale E Newbury; Frederick W Miller; Pamela G Robey; Lisa G Rider
Journal:  Arthritis Res Ther       Date:  2009-10-26       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.